Documents
Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;ORAL | 5MG/5ML (1MG/ML) | 1 | CORLANOR | IVABRADINE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2019-04-22 | PRIORITY |
LABELING; Labeling | SUPPL | 2 | AP | 2021-08-04 | STANDARD |
Submissions Property Types
CDER Filings
AMGEN INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209964
[companyName] => AMGEN INC
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/209964lbl.pdf#page=24"]
[products] => [{"drugName":"CORLANOR","activeIngredients":"IVABRADINE","strength":"5MG\/5ML (1MG\/ML)","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"04\/22\/2019","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209964lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/22\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209964lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/209964Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2019\\\/209964Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2019-04-22
)
)